US drugmakers Bristol Myers and Pfizer said on Thursday that they will make their blood thinner, Eliquis, available directly ...

The joint venture is launching a direct-to-consumer service of Eliquis after discussions with the Trump administration.

Pfizer acquired Seagen in 2023 for $43 billion, and shut down construction on a $350 million manufacturing facility the ...

David Katz, CIO at Matrix Asset Advisors, tells 'Worldwide Exchange' the market is jittery, tech looks overbought, and Pfizer ...

Discover the current pipeline candidates advancing through the clinic for the treatment of sickle cell disease.

Drugmaker Pfizer is warning doctors that it expects to run low on supplies of Bicillin L-A, a long-acting injection of the ...

A recalled sickle cell drug is drawing new scrutiny from attorneys who say it may have done more harm than good, possibly ...

Since not every study can be replicated prior to publication, it’s important to conduct replications after studies are published. Replications help scientists understand how well research processes ...

Australia ‘undervalues’ the products of drug companies, Pfizer has told the Productivity Commission, echoing US lobbyists ...

Biohaven’s valuation has dropped from $3.9B to $1.42B, but no revenue and high cash burn still limit its appeal. Read why ...

Zohran Mamdani told a group of top business leaders in New York City on Tuesday that he would discourage the use of the ...